Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]>

Marta Bustaffa; Isabelle Koné-Paut; Seza Ozen; Gayane Amaryan; Efimia Papadopoulou-Alataki; Romina Gallizzi; Maria Carrabba; Yonatan Butbul Aviel; Luca Cantarini; Maria Alessio; Jordi Anton; Laura Obici; Faysal Gok; Ezgi Deniz Batu; Estefania Moreno; Paul Brogan; Maria Trachana; Gabriele Simonini; Donato Rigante; Yosef Uziel; Antonella Insalaco; Maria Cristina Maggio; Nicolino Ruperto; Marco Gattorno; L Rossi Semerano

doi:10.1016/j.semarthrit.2022.152123

Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]>

Marta Bustaffa, Isabelle Koné-Paut, Seza Ozen, Gayane Amaryan, Efimia Papadopoulou-Alataki, Romina Gallizzi, Maria Carrabba, Yonatan Butbul Aviel, Luca Cantarini, Maria Alessio, Jordi Anton, Laura Obici, Faysal Gok, Ezgi Deniz Batu, Estefania Moreno, Paul Brogan, Maria Trachana, Gabriele Simonini, Donato Rigante, Yosef UzielAntonella Insalaco, Maria Cristina Maggio, Nicolino Ruperto, Marco Gattorno, L Rossi Semerano

Research output: Contribution to journal › Article

Abstract

The authors regret < for the oversight to mention that this work has been done on behalf of the Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) >. The authors would like to apologise for any inconvenience caused. ____________________________ DOI of original article: < 10.1016/j.semarthrit.2022.151957>

Original language	English
Pages (from-to)	N/A-N/A
Journal	Seminars in Arthritis and Rheumatism
Volume	58
DOIs	https://doi.org/10.1016/j.semarthrit.2022.152123
Publication status	Published - 2023

Keywords

Autoinflammation

Access to Document

10.1016/j.semarthrit.2022.152123

Fingerprint

Dive into the research topics of 'Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]>'. Together they form a unique fingerprint.

Cite this

Bustaffa, M., Koné-Paut, I., Ozen, S., Amaryan, G., Papadopoulou-Alataki, E., Gallizzi, R., Carrabba, M., Aviel, Y. B., Cantarini, L., Alessio, M., Anton, J., Obici, L., Gok, F., Batu, E. D., Moreno, E., Brogan, P., Trachana, M., Simonini, G., Rigante, D., ... Semerano, L. R. (2023). Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]> Seminars in Arthritis and Rheumatism, 58, N/A-N/A. https://doi.org/10.1016/j.semarthrit.2022.152123

Bustaffa, Marta ; Koné-Paut, Isabelle ; Ozen, Seza et al. / Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]>. In: Seminars in Arthritis and Rheumatism. 2023 ; Vol. 58. pp. N/A-N/A.

@article{0647ed030006432ea329d24391213f5d,

title = "Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]>",

abstract = "The authors regret < for the oversight to mention that this work has been done on behalf of the Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) >. The authors would like to apologise for any inconvenience caused. ____________________________ DOI of original article: < 10.1016/j.semarthrit.2022.151957>",

keywords = "Autoinflammation, Autoinflammation",

author = "Marta Bustaffa and Isabelle Kon{\'e}-Paut and Seza Ozen and Gayane Amaryan and Efimia Papadopoulou-Alataki and Romina Gallizzi and Maria Carrabba and Aviel, {Yonatan Butbul} and Luca Cantarini and Maria Alessio and Jordi Anton and Laura Obici and Faysal Gok and Batu, {Ezgi Deniz} and Estefania Moreno and Paul Brogan and Maria Trachana and Gabriele Simonini and Donato Rigante and Yosef Uziel and Antonella Insalaco and Maggio, {Maria Cristina} and Nicolino Ruperto and Marco Gattorno and Semerano, {L Rossi}",

year = "2023",

doi = "10.1016/j.semarthrit.2022.152123",

language = "English",

volume = "58",

pages = "N/A--N/A",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W B Saunders Company:Fulfillment Department, The Curtis Center, Independence Square West:Philadelphia, PA 19106:(800)654-2452, (215)238-7800, EMAIL: [email protected], INTERNET: http://elsevierhealth.com, Fax: (215)238-6445",

}

Bustaffa, M, Koné-Paut, I, Ozen, S, Amaryan, G, Papadopoulou-Alataki, E, Gallizzi, R, Carrabba, M, Aviel, YB, Cantarini, L, Alessio, M, Anton, J, Obici, L, Gok, F, Batu, ED, Moreno, E, Brogan, P, Trachana, M, Simonini, G, Rigante, D, Uziel, Y, Insalaco, A, Maggio, MC, Ruperto, N, Gattorno, M & Semerano, LR 2023, 'Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]>', Seminars in Arthritis and Rheumatism, vol. 58, pp. N/A-N/A. https://doi.org/10.1016/j.semarthrit.2022.152123

Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]> / Bustaffa, Marta; Koné-Paut, Isabelle; Ozen, Seza et al.
In: Seminars in Arthritis and Rheumatism, Vol. 58, 2023, p. N/A-N/A.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]>

AU - Bustaffa, Marta

AU - Koné-Paut, Isabelle

AU - Ozen, Seza

AU - Amaryan, Gayane

AU - Papadopoulou-Alataki, Efimia

AU - Gallizzi, Romina

AU - Carrabba, Maria

AU - Aviel, Yonatan Butbul

AU - Cantarini, Luca

AU - Alessio, Maria

AU - Anton, Jordi

AU - Obici, Laura

AU - Gok, Faysal

AU - Batu, Ezgi Deniz

AU - Moreno, Estefania

AU - Brogan, Paul

AU - Trachana, Maria

AU - Simonini, Gabriele

AU - Rigante, Donato

AU - Uziel, Yosef

AU - Insalaco, Antonella

AU - Maggio, Maria Cristina

AU - Ruperto, Nicolino

AU - Gattorno, Marco

AU - Semerano, L Rossi

PY - 2023

Y1 - 2023

N2 - The authors regret < for the oversight to mention that this work has been done on behalf of the Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) >. The authors would like to apologise for any inconvenience caused. ____________________________ DOI of original article: < 10.1016/j.semarthrit.2022.151957>

AB - The authors regret < for the oversight to mention that this work has been done on behalf of the Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) >. The authors would like to apologise for any inconvenience caused. ____________________________ DOI of original article: < 10.1016/j.semarthrit.2022.151957>

KW - Autoinflammation

UR - http://hdl.handle.net/10807/244047

U2 - 10.1016/j.semarthrit.2022.152123

DO - 10.1016/j.semarthrit.2022.152123

M3 - Article

SN - 0049-0172

VL - 58

SP - N/A-N/A

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

ER -

Bustaffa M, Koné-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R et al. Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)): <[ Seminars in Arthritis and Rheumatism Volume 52, 151957]> Seminars in Arthritis and Rheumatism. 2023;58:N/A-N/A. doi: 10.1016/j.semarthrit.2022.152123

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this